Virus-binding Protein Technology Derived from Beans
Norovirus is a highly contagious non-enveloped virus responsible for causing >90% of viral gastroenteritis, and >50% of all gastroenteritis outbreaks worldwide. According to the WHO, norovirus causes an estimated 685 million cases of infection and 200,000 deaths per year. Its resilience poses challenges for eradication through altering pH, heat exposure, or common disinfectants. Notably, alcohol-based hand sanitisers are not as effective against this virus, according to the US CDC.
To address this, a biotech company has successfully developed a novel virus-binding protein technology derived from jack beans or sword beans. This patented lectin protein exhibits antiviral properties and has demonstrated the ability to neutralise not only norovirus, but also coronavirus and Hepatitis A virus. It has also demonstrated activity against Escherichia coli bacteria.
By utilising this innovative technology, viral outbreaks can be prevented. This versatile lectin protein can be incorporated as an active ingredient into various product formulations. The technology owner is especially interested to work with companies from health service sectors, and personal care product manufacturers.